Prevalence of HPV in HIV-Infected Women in the Designated AIDS Center at Upstate Medical University and the Potential Benefit of Vaccination Regardless of Age

Journal of the Association of Nurses in AIDS Care

Volumn 24, Issue 2, 2013, Pages 176-179

  Feola, Theresa D ^a   Albert, Mary Beth ^a   Shahabi, Kamnoosh ^a   Endy, Timothy ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Age; HIV; HPV; Vaccination; Women

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLASSIFICATION; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; MIXED INFECTION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; UNITED STATES; UNIVERSITY HOSPITAL; UTERINE CERVIX; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VACCINATION; VAGINA SMEAR; VIROLOGY; VIRUS LOAD;

ADULT; AGE DISTRIBUTION; AGED; CD4 LYMPHOCYTE COUNT; CERVIX UTERI; COINFECTION; DNA, VIRAL; FEMALE; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; NEW YORK; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VACCINATION; VAGINAL SMEARS; VIRAL LOAD;

EID: 84873715914     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2012.03.003     Document Type: Article

References (11)

1. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report 2010, 59(20):630-632. Centers for Disease Control and Prevention, Retrieved from. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a5.htm.
2. Centers for Disease Control and Prevention. (2010b). Sexually transmitted disease surveillance 2010. Retrieved from . http://www.cdc.gov/std/stats.
3. Clifford G.M., Goncalves M.A.G., Franceschi S. Human papillomavirus types among women infected with HIV: A meta-analysis. AIDS 2006, 20(18):2337-2344. 10.1097/01.aids.0000253361.63578.14.
4. Heard I. Human papillomavirus, cancer and vaccination. Current Opinion in HIV & AIDS 2011, 6(4):297-302. 10.1097/COH.0b013e328347335d.
5. Luque A.E., Jabeen M., Messing S., Lane C.A., Demeter L., Rose R., Reichman R. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1 infected women in Rochester, New York. Journal of Infectious Diseases 2006, 192(4):428-434. 10.1086/505876.
6. National Cancer Institute. (2011). Fact sheet: Human papillomavirus (HPV) vaccines. Retrieved from . http://www.cancer.gov/cancertopics/factsheet/prevention/HPV-vaccine.
7. Palefsky J.M. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Current Opinion in Oncology 2003, 15(5):382-388. 10.1097/00001622-200309000-00007.
8. Rowhani-Rahbar A., Hawes S.E., Sow P.S., Toure P., Feng Q., Dem A., Kiviat N., et al. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. Journal of Infectious Diseases 2007, 196(6):887-894. 10.1086/520883.
9. Schiller J.T., Day P.M., Kines R.C. Current understanding of the mechanism of HPV infection. Gynecologic Oncology 2010, 118(1 Suppl. 1):S12-S17. 10.1016/j.ygyno.2010.04.004.
10. Thaczuk, D. (2006). HIV-positive women often infected with multiple HPV subtypes. Retrieved from . http://aidsmap.com/HIV-positive-women-often-infected-with-multiple-HPV-subtypes/page/1425813/.
11. Velicer C., Zhu X., Vuocolo S., Liaw K.L., Saah A. Prevalence and incidence of HPV genital infection in women. Sexually Transmitted Diseases 2009, 36(11):696-703. 10.1097/OLQ.0b013e3181ad25ff.